Abstract
T helper type 1 (TH1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As interleukin 18 (IL-18) is a cofactor with IL-12 in promoting TH1 cell development, we examined the function of IL-18 and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice, IL-18-deficient mice were susceptible to experimental autoimmune encephalomyelitis. In contrast, IL-18Rα-deficient mice were resistant to experimental autoimmune encephalomyelitis, indicating involvement of an IL-18Rα ligand other than IL-18 with encephalitogenic properties. Moreover, engagement of IL-18Rα on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus, IL-18 and TH1 cells are dispensable, whereas IL-18Rα and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
O'Garra, A., Steinman, L. & Gijbels, K. CD4+ T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9, 872–883 (1997).
Brand, D.D., Kang, A.H. & Rosloniec, E.F. Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25, 3–18 (2003).
Renno, T., Krakowski, M., Piccirillo, C., Lin, J.Y. & Owens, T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154, 944–953 (1995).
Merrill, J.E. et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89, 574–578 (1992).
Racke, M.K. et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961–1966 (1994).
van der Veen, R.C. & Stohlman, S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48, 213–220 (1993).
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237–1240 (1994).
Frei, K. et al. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 2177–2182 (1997).
Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B. & Ramshaw, I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223–3227 (1996).
Chu, C.Q., Wittmer, S. & Dalton, D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123–128 (2000).
Ferber, I.A. et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5–7 (1996).
Becher, B., Durell, B.G. & Noelle, R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110, 493–497 (2002).
Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).
Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
Okamura, H. et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88–91 (1995).
Dinarello, C.A. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103, 11–24 (1999).
Dinarello, C.A. Interleukin-18. Methods 19, 121–132 (1999).
Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998).
Suzuki, N. et al. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J. Immunol. 170, 4031–4035 (2003).
O'Neill, L.A. & Dinarello, C.A. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21, 206–209 (2000).
Kaser, A. et al. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood 103, 648–655 (2004).
Tomura, M. et al. Differential capacities of CD4+, CD8+, and CD4−CD8− T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18. J. Immunol. 160, 3759–3765 (1998).
Xu, D. et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188, 1485–1492 (1998).
Yoshimoto, T. et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol. 161, 3400–3407 (1998).
Boraschi, D. et al. Cytokines in inflammation. Joint Workshop of the Deutsche Gesellschaft fur Immunologie (DGfI) and the Gruppo di Cooperazione in Immunologia (GCI) Assergi (L'Aquila, Italy), February 8–11, 1998. Eur. Cytokine Netw. 9, 205–212 (1998).
Torigoe, K. et al. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272, 25737–25742 (1997).
Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).
Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104–7110 (2002).
Gran, B. et al. Early administration of IL-12 suppresses EAE through induction of interferon-γ. J. Neuroimmunol. 156, 123–131 (2004).
Wei, X.Q. et al. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163, 2821–2828 (1999).
Kinjo, Y. et al. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol. 169, 323–329 (2002).
Santos, L.L. et al. IL-18 is redundant in T-cell responses and in joint inflammation in antigen-induced arthritis. Immunol. Cell Biol. 84, 166–173 (2006).
Hoshino, K. et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162, 5041–5044 (1999).
Hickey, W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97–105 (1991).
Wekerle, H., Sun, D., Oropeza-Wekerle, R.L. & Meyermann, R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 132, 43–57 (1987).
McColl, S.R. et al. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161, 6421–6426 (1998).
Becher, B., Durell, B.G. & Noelle, R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112, 1186–1191 (2003).
Shi, F.D., Takeda, K., Akira, S., Sarvetnick, N. & Ljunggren, H.G. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J. Immunol. 165, 3099–3104 (2000).
Leung, B.P. et al. A role for IL-18 in neutrophil activation. J. Immunol. 167, 2879–2886 (2001).
Becher, B., Durell, B.G., Miga, A.V., Hickey, W.F. & Noelle, R.J. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193, 967–974 (2001).
Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328–334 (2005).
Vermot-Desroches, C. et al. Monoclonal antibodies specific for the IL-18 receptor. Cell. Immunol. 236, 101–104 (2005).
Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715–725 (2000).
Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003).
Harrington, L.E. et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
Su, S.B. et al. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 175, 6303–6310 (2005).
Jiang, H.R. et al. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 177–182 (2001).
Sims, J.E. IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol. 14, 117–122 (2002).
Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).
Stockinger, B. & Hausmann, B. Functional recognition of in vivo processed self antigen. Int. Immunol. 6, 247–254 (1994).
Acknowledgements
We thank H. Hofstetter (University of Wurzburg, Wurzburg, Germany) and V. Woertmann (University of Zurich, Zurich, Switzerland) for technical assistance; and E. Saller and T. Buch (University of Zurich, Zurich, Switzerland) for critical review of this manuscript. Supported by the Swiss National Science Foundation (B.B.), the National Center for Competence in Research (B.B.), the Swiss Multiple Sclerosis Society (B.B.), the Hertie Foundation (B.B. & M.P.), Serono Pharmaceuticals Geneva (B.B.), the Center for Neuroscience Research in Zurich (I.G.), Roche Research Foundation (EU) and the National Multiple Sclerosis Society (Harry Weaver Neuroscience scholar; B.B.).
Author information
Authors and Affiliations
Contributions
I.G. did all the experiments unless stated otherwise; E.U. helped with the generation of experimentation and analysis of bone marrow–chimeric mice; K.W. and M.P. analyzed the histopathological data; and B.B. and I.G. designed all the experiments and prepared the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Il18−/− LN cells do not produce IL-18. (PDF 350 kb)
Supplementary Fig. 2
CD4+ T cells from Il18−/− and Il18r1−/− mice are capable of IFN-γ production. (PDF 340 kb)
Supplementary Fig. 3
Analysis of inflammatory infiltrates, cytokines and chemokines in MOG(35-55)-immunized mice. (PDF 1188 kb)
Supplementary Fig. 4
Intracellular staining for IL-17 and IFN-γ. (PDF 347 kb)
Supplementary Table 1
IL-18Rα Ab does not affect the cell composition of the peripheral immune compartment. (PDF 345 kb)
Rights and permissions
About this article
Cite this article
Gutcher, I., Urich, E., Wolter, K. et al. Interleukin 18–independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat Immunol 7, 946–953 (2006). https://doi.org/10.1038/ni1377
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1377
This article is cited by
-
IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes
Journal of Neuroinflammation (2022)
-
Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis
Acta Neuropathologica Communications (2019)
-
Bone marrow chimeras—a vital tool in basic and translational research
Journal of Molecular Medicine (2019)
-
Absence of system xc − on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis
Journal of Neuroinflammation (2017)
-
Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
Mucosal Immunology (2015)